| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And COO | Chief Business Officer | See Remarks
2 companies
McNeill Jonathan is a President And COO at CBIO with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 23 sells.
Estimated insider holdings value: $5.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2024 | DYN Dyne Therapeutics, Inc. | Chief Business Officer | Sell | 2,705 | $45.12 | $122,054.00 | -1.0% | -36.4% | -73.4% | |
| Jun 11, 2024 | DYN Dyne Therapeutics, Inc. | Chief Business Officer | Sell | 1,823 | $31.34 | $57,132.82 | -1.3% | +4.9% | -52.9% | |
| May 16, 2024 | DYN Dyne Therapeutics, Inc. | Chief Business Officer | Sell | 2,774 | $28.27 | $78,419.85 | -1.0% | +52.6% | -58.9% | |
| Mar 11, 2024 | DYN Dyne Therapeutics, Inc. | Chief Business Officer | Sale+OE | 109,601 | $26.11 | $2,861,373.09 | -12.6% | +23.3% | -52.9% | |
| Mar 7, 2024 | DYN Dyne Therapeutics, Inc. | Chief Business Officer | Sell | 2,434 | $25.85 | $62,918.90 | -1.7% | +24.4% | -53.1% | |
| Mar 1, 2024 | DYN Dyne Therapeutics, Inc. | Chief Business Officer | Sale+OE | 28,528 | $28.46 | $811,865.05 | -4.6% | +7.1% | -53.3% | |
| Jan 26, 2024 | DYN Dyne Therapeutics, Inc. | Chief Business Officer | Sale+OE | 20,000 | $24.53 | $490,510.36 | -6.5% | +12.0% | -35.2% | |
| Jan 4, 2024 | DYN Dyne Therapeutics, Inc. | Chief Business Officer | Sale+OE | 31,900 | $16.59 | $529,194.30 | -5.2% | +48.3% | +27.7% | |
| Dec 11, 2023 | DYN Dyne Therapeutics, Inc. | Chief Business Officer | Sell | 1,245 | $10.72 | $13,346.40 | -0.8% | +134.4% | +159.9% | |
| Sep 18, 2023 | DYN Dyne Therapeutics, Inc. | Chief Business Officer | Sell | 1,261 | $9.41 | $11,866.01 | -2.0% | +21.1% | +251.3% |